Jump to content

Niacin/simvastatin: Difference between revisions

Content deleted Content added
SentoDude (talk | contribs)
m misspelling, added link
 
(20 intermediate revisions by 17 users not shown)
Line 1: Line 1:
{{Short description|Combination drug}}
{{Drugbox
{{Drugbox
| verifiedrevid = 388938186
| type = combo
| type = combo
| image = Niacinstr.png
| image = Niacinstr.png
| image2 = Simvastatin.svg
| image2 = Simvastatin.svg
| component1 = Niacin
| component1 = Niacin
| class1 = n/a
| class1 =
| component2 = Simvastatin
| component2 = Simvastatin
| class2 = [[Statin]]
| class2 = [[Statin]]
| CAS_number =
| CAS_number =
| ATC_prefix =
| ATC_prefix =
| ATC_suffix =
| ATC_suffix =
Line 22: Line 24:
| routes_of_administration = Oral
| routes_of_administration = Oral
}}
}}
'''Simcor''' ([[Abbott Laboratories|Abbott]]) is a drug combination of the statin drug [[Simvastatin]] and an extended release form of niacin used for the treatment of [[dyslipidemia]]. It was approved by the FDA on February 15, 2008.<ref>{{Cite web|url=http://www.drugs.com/newdrugs/abbott-receives-fda-approval-simcor-niaspan-simvastatin-novel-combination-medicine-comprehensive-846.html |title=Drugs.com, Abbott Receives FDA Approval for Simcor (Niaspan / simvastatin), a Novel Combination Medicine for Comprehensive Cholesterol Management |accessdate=2008-03-15 |work= }}</ref>
'''''' ([[Abbott Laboratories|Abbott]]) is a drug of the drug [[]] and niacin used for the treatment of [[dyslipidemia]]. It was approved by the FDA on February 15, 2008.<ref>{{Cite web|url=://www.drugs.com/newdrugs/abbott-receives-fda-approval-simcor-niaspan-simvastatin-novel-combination-medicine-comprehensive-846.html |title=Drugs.com, Abbott Receives FDA Approval for Simcor (Niaspan / simvastatin), a Novel Combination Medicine for Comprehensive Cholesterol Management |accessdate=2008-03-15 |= }}</ref>


==References==
==References==
Line 29: Line 31:
{{Statins}}
{{Statins}}


{{DEFAULTSORT:Niacin simvastatin}}

[[Category:Combination drugs]]

[[Category:Drugs developed by AbbVie]]




{{Cardiovascular-drug-stub}}
{{Cardiovascular-drug-stub}}

[[Category:Hypolipidemic agents]]
[[Category:Combination drugs]]